Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 6.090 | 6.090 | 0.000 |
Shares | 93.850 | 93.850 | 0.000 |
Convertible | 0.110 | 0.110 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 29.488 | 24.124 |
Price to Book | 3.072 | 3.013 |
Price to Sales | 6.502 | 3.867 |
Price to Cash Flow | 21.300 | 15.880 |
Dividend Yield | 1.379 | 1.889 |
5 Years Earnings Growth | 10.368 | 13.292 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 99.990 | 95.436 |
Technology | 0.010 | 0.421 |
Number of long holdings: 72
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
APT Medical | CNE100004C45 | 9.40 | 346.67 | -3.71% | |
New Industries | CNE100003T39 | 8.86 | 68.03 | +1.45% | |
Jiangsu Hengrui | CNE0000014W7 | 8.86 | 48.68 | +1.44% | |
Hangzhou Tigermed Consulting | CNE100001KV8 | 7.77 | 67.95 | +6.37% | |
Sinopep Allsino Bio Pharmaceutical Co | CNE1000051X5 | 6.98 | 51.34 | +3.51% | |
Shenzhen YHLO Biotech Co | CNE100005204 | 5.17 | 18.30 | +3.10% | |
Kelun Pharm A | CNE100000PW7 | 5.07 | 32.97 | -0.12% | |
Sansure Biotech | CNE1000043J1 | 4.93 | 23.52 | +1.91% | |
RemeGen | CNE100005B03 | 4.20 | 36.35 | +0.61% | |
Hunan Fangsheng Pharm | CNE100001VG6 | 3.30 | 12.29 | -0.49% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
E Fund CSI China Oversea Net 50 | 44.1B | 37.73 | -2.57 | - | ||
E Fund Blue Chip Selected Mixed | 39.04B | 12.77 | -9.26 | - | ||
E Fund Consumer Sector | 22.07B | 11.76 | -5.44 | 14.63 | ||
E Fund SSE50 Index | 20.67B | 21.59 | -2.10 | 12.47 | ||
E Fund CSI300 ETF Feeder Fund | 19.61B | 18.25 | -3.82 | 7.08 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review